Enanta Pharmaceuticals
ENTA
#8906
Rank
โ‚ฌ98.07 M
Marketcap
4,60ย โ‚ฌ
Share price
-4.72%
Change (1 day)
-70.18%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2024 (TTM): -โ‚ฌ89.88 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ66.59 Million. , an increase over its 2023 earnings that were of -โ‚ฌ0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ88.32 Million-23.87%
2023 -โ‚ฌ0.12 Billion4.39%
2022 -โ‚ฌ0.12 Billion-4.4%
2021 -โ‚ฌ0.12 Billion91.12%
2020 -โ‚ฌ60.83 Million-407.13%
2019 โ‚ฌ19.8 M-78.63%
2018 โ‚ฌ92.68 M117.97%
2017 โ‚ฌ42.52 M-574.65%
2016 -โ‚ฌ8.96 Million-110.83%
2015 โ‚ฌ82.74 M-4.5%
2014 โ‚ฌ86.63 M-638.53%
2013 -โ‚ฌ16.09 Million-137.98%
2012 โ‚ฌ42.35 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ3.38 B-3,930.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.87 B-18,080.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.25 B-387.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.30 B-21,961.99%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ7.63 Billion 8,537.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.41 B-14,161.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland